tiprankstipranks
Advertisement
Advertisement

Baijin Life Science Holdings Reports Goodwill Impairment Amid Strategic Shift

Story Highlights
Baijin Life Science Holdings Reports Goodwill Impairment Amid Strategic Shift

Claim 55% Off TipRanks

Affluent Partners Holdings ( (HK:1466) ) just unveiled an update.

Baijin Life Science Holdings Limited, operating in the skincare industry, has announced a supplemental update to its 2025 Annual Report. The company recognized a goodwill impairment of approximately HK$20 million related to its acquisition of Tonnett Julis Holdings Limited. This impairment was due to the underperformance of Tonnett Group, particularly in its online sales strategy, which led to a shift towards partnering with larger distributors and the development of a flagship beauty club. The company believes this strategic pivot will benefit long-term growth but has temporarily decreased revenue.

The most recent analyst rating on (HK:1466) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Affluent Partners Holdings stock, see the HK:1466 Stock Forecast page.

More about Affluent Partners Holdings

Average Trading Volume: 481,702

Technical Sentiment Signal: Sell

Current Market Cap: HK$472.9M

For an in-depth examination of 1466 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1